10.10.25
7 min. Read

Revisiting E&O scoops, pricing intel, revenue finds

Issue 349

Welcome back to E&O: a paying subscribers-only weekly newsletter focused on three areas of health tech: FDA-regulated software devices, digital health as an employee benefit, and national virtual clinics.

 Exits & Outcomes Newsletter

This week's newsletter revisits some of E&O's reporting from this past year along with some updates and new commentary. Read on below for more. Was this forwarded to you? Click this link for more info

Subscribers Only

It's a good one, too.

This digital health research is for Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and read through the Exits & Outcomes archives. Enter your email below to subscribe today!

×

Newsletters

Filter by
All Selling to Employers Prescription Digital Therapeutics National Virtual Clinics
    408 articles
  • First
  • Previous
    • 1 of 41
  • Next
  • Last
HLTH acquisition price. Estimating Pomelo Care pricing, revenue, and more
1.09.26
7 min. Read
CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.
11.07.25
6 min. Read
Pricing for Sword Health, Hinge Health, Joint Academy in the UK.
10.31.25
7 min. Read
Spring, Slingshot AI, Click and others write FDA about GenAI. Big Health board departs.
10.24.25
7 min. Read
Cigna clarifies new non-coverage policy for PDTs. Bevel $10M. FDA GenAI comments.
10.17.25
5 min. Read
Big Health’s 2024 revenue shrinks. 2025: Runway worries.
9.26.25
5 min. Read
Kavira Health pricing. What did Swing Therapeutics buy? PFS Comments.
9.18.25
7 min. Read
Cerebral’s $25M M&A. Amazon-Fay. Oshi growth numbers.
9.12.25
4 min. Read
Letters to CMS: DMHT codes, MDPP pricing, more. Plus: Unannounced funding.
9.05.25
6 min. Read
Pricing updates: Teladoc, Maven, Garner, Kaia and more
8.29.25
4 min. Read
  • First
  • Previous
    • 1 of 41
  • Next
  • Last